Area of research
Genetics · Oncology
Research interest
Research focused on Glioma and Guideline, with related work in ATRX, IDH1, Radiation therapy. Notable publications include 'CGCG clinical practice guidelines for the management of adult diffuse gliomas', 'Induction Therapy With Autologous Mesenchymal Stem Cells in Living-Related Kidney Transplants', and 'Clinical practice guidelines for the management of adult diffuse gliomas'.
2094O SKYSCRAPER-07: A phase III, randomised study of atezolizumab (atezo) with or without tiragolumab (tira) in patients (pts) with unresectable esophageal squamous cell carcinoma (ESCC) that has not progressed following definitive concurrent chemoradiotherapy (dCRT)
From pathology to therapy: A comprehensive review of ATRX mutation related molecular functions and disorders
Updated clinical practice guidelines for the management of adult diffuse gliomas
Immunotherapeutic strategies targeting the PVR–TIGIT/CD96/CD226 signaling pathway in glioma treatment
Unveiling the role of TAGLN2 in glioblastoma: From proneural-mesenchymal transition to Temozolomide resistance
A novel protein SPECC1-415aa encoded by N6-methyladenosine modified circSPECC1 regulates the sensitivity of glioblastoma to TMZ
Insights of immune cell heterogeneity, tumor-initiated subtype transformation, drug resistance, treatment and detecting technologies in glioma microenvironment
GRAVEN: a database of teaching method that applies gestures to represent the neurosurgical approach’s blood vessels and nerves
AB002. DNA methylation-regulated genes contribute to temozolomide (TMZ) resistance by scaffolding paraspeckle proteins
Histone lactylation-derived LINC01127 promotes the self-renewal of glioblastoma stem cells via the cis-regulating the MAP4K4 to activate JNK pathway
RETRACTED: Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma
Prevention of chronic diabetic complications in type 1 diabetes by co-transplantation of umbilical cord mesenchymal stromal cells and autologous bone marrow: a pilot randomized controlled open-label clinical study with 8-year follow-up
Dexamethasone and compliance affect TTFields efficacy to glioblastoma patients: a systematic review and meta-analysis
A Voxel-Based Radiographic Analysis Reveals the Biological Character of Proneural-Mesenchymal Transition in Glioblastoma
Clinical practice guidelines for the management of adult diffuse gliomas
Mutant IDH1 Enhances Temozolomide Sensitivity via Regulation of the ATM/CHK2 Pathway in Glioma
Review of clinical nerve repair strategies for neurorestoration of central nervous system tumor damage
Erythrocyte-rich thrombi related to serum iron contribute to single stent retrieval and favorable clinical outcomes in acute ischemic stroke by endovascular treatment
Risk of Adverse Vascular Events in Patients with Malignant Glioma Treated with Bevacizumab Plus Irinotecan: A Systematic Review and Meta-Analysis
Nanocomposites Inhibit the Formation, Mitigate the Neurotoxicity, and Facilitate the Removal of β-Amyloid Aggregates in Alzheimer’s Disease Mice
Anti-β2GPI/β2GPI induces neutrophil extracellular traps formation to promote thrombogenesis via the TLR4/MyD88/MAPKs axis activation
ALDH1A3 induces mesenchymal differentiation and serves as a predictor for survival in glioblastoma
Recent Advances in Targeted Therapy for Glioma
CGCG clinical practice guidelines for the management of adult diffuse gliomas
Classification based on mutations of<i>TERT</i>promoter and<i>IDH</i>characterizes subtypes in grade II/III gliomas
Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas
ATRX, IDH1-R132H and Ki-67 immunohistochemistry as a classification scheme for astrocytic tumors
Evolving Molecular Genetics of Glioblastoma
Bioinformatic Profiling Identifies a Glucose-Related Risk Signature for the Malignancy of Glioma and the Survival of Patients
Gene Expression Profiling Stratifies IDH1-Mutant Glioma with Distinct Prognoses